首页> 外文OA文献 >Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer.
【2h】

Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer.

机译:全甲状腺切除术即使在分化型甲状腺癌的高危患者中也不能提高疾病控制或生存率。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

SUMMARY BACKGROUND DATA: The extent of primary thyroidectomy for differentiated thyroid cancer is controversial. There are strong proponents for total thyroidectomy based on its presumed and theoretical disease control benefits. In contrast, there are equally strong advocates of less aggressive thyroidectomy with its lower hazard of parathyroid and recurrent nerve injury. The authors have addressed whether total thyroidectomy has a survival benefit justifying its use in patients with high-risk primary cancer. The major risk factors include age and the following the pathologic determinants follicular histology, vascular invasion, and extracapsular extension. MATERIALS AND METHODS: The clinical pathologic, therapeutic, prognostic, and outcome data were reviewed in 347 patients with well-differentiated thyroid cancer. Seventy-five percent were women, 216 patients were in the younger age group (low-risk) (21-50 years), 103 were in the intermediate-risk group (51-70 years), and 28 were in the high-risk group (>70 years). Included in the high-risk pathologic category were 158 patients who had follicular histology (55), extracapsular extension (107), or vascular invasion (119). Total thyroidectomy was performed in 56 patients, near or subtotal thyroidectomy in 47 patients and lobectomy in 55 patients. The 10-year disease specific survival in the overall patient group was 82% in patients with total thyroidectomy, 78% in patients with subtotal thyroidectomy, and 89% in patients with lobectomy (p = 0.30). There was no significant survival difference according to extent of thyroidectomy in the intermediate or high-risk groups either by age or in patients who had high-risk pathologic feature. CONCLUSIONS: Total thyroidectomy in high-risk patients with differentiated thyroid cancer (containing follicular histology, vascular invasion, or extracapsular extension) showed no benefit over partial thyroidectomy. This suggests that the general use of total thyroidectomy is not indicated, except in highly selected patients.
机译:摘要背景资料:分化型甲状腺癌的原发性甲状腺切除术的范围存在争议。基于全甲状腺切除术的推定和理论上的疾病控制益处,有很强的支持者。相比之下,同样有强烈的主张提倡较不积极的甲状腺切除术,因为它对甲状旁腺和反复神经损伤的危害较小。作者研究了全甲状腺切除术是否具有生存优势,证明其在高危原发性癌症患者中的使用是合理的。主要危险因素包括年龄和以下病理决定因素:卵泡组织学,血管浸润和囊外扩张。材料与方法:对347例高分化甲状腺癌患者的临床病理,治疗,预后和结局数据进行了回顾。女性占75%,年轻人群(低风险)(21至50岁)为216例患者,中危人群(51-70岁)为103例,高危人群为28例组(> 70年)。高危病理学类别包括158例行滤泡组织学检查(55),囊外扩张(107)或血管侵犯(119)的患者。全甲状腺切除术56例,近或全甲状腺切除术47例,肺叶切除术55例。在整个患者组中,全甲状腺切除术患者的10年疾病特异性存活率为82%,甲状腺全切除术患者为78%,肺叶切除术患者为89%(p = 0.30)。在中等或高危组中,按年龄和具有高危病理特征的患者,根据甲状腺切除术的程度,生存率无明显差异。结论:分化型甲状腺癌(包含滤泡组织学,血管浸润或囊外扩张)的高危患者全甲状腺切除术未显示优于部分甲状腺切除术的益处。这表明除高度选择的患者外,不建议一般使用全甲状腺切除术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号